scholarly journals Review: Economic evidence of preventive interventions for anxiety disorders in children and adolescents – a systematic review

2021 ◽  
Author(s):  
Vartiainen Anna‐Kaisa ◽  
Kuvaja‐Köllner Virpi ◽  
Rantsi Mervi ◽  
Rissanen Elisa ◽  
Luntamo Terhi ◽  
...  
Keyword(s):  
Systematic Review ◽  
Anxiety Disorders ◽  
Children And Adolescents ◽  
Economic Evidence ◽  
Preventive Interventions

Prenatal and perinatal risk factors for anxiety disorders among children and adolescents: A systematic review

2020 ◽  
Vol 277 ◽  
pp. 85-93
Author(s):  
Tiia Ståhlberg ◽  
Prakash Khanal ◽  
Roshan Chudal ◽  
Terhi Luntamo ◽  
Kim Kronström ◽  
...  
Keyword(s):  
Risk Factors ◽  
Systematic Review ◽  
Anxiety Disorders ◽  
Children And Adolescents ◽  
Perinatal Risk Factors ◽  
Perinatal Risk

scholarly journals Cognitive-behavioral therapy for anxiety disorders in children and adolescents: a systematic review of follow-up studies

2014 ◽  
Vol 63 (4) ◽  
pp. 373-378 ◽  
Author(s):  
Roberta Davis ◽  
Maria Augusta Mansur de Souza ◽  
Roberta Rigatti ◽  
Elizeth Heldt
Keyword(s):  
Systematic Review ◽  
Cognitive Behavioral Therapy ◽  
Anxiety Disorders ◽  
Children And Adolescents ◽  
Behavioral Therapy ◽  
Cognitive Behavioral ◽  
Control Group ◽  
Term Response

Objective To conduct a systematic review about the long-term response to cognitive-behavioral therapy (CBT) for anxiety disorders (ADs) in children and adolescents. Methods The PubMed and ISI Web of Science databases were consulted. Search in the databases was performed in November 2012 and included cohort studies after CBT for ADs in children and adolescents with a follow-up period over 12 months. Results A total of 10 papers met the inclusion criteria. The follow-up period ranged from 12 months to 13 years and the results generally showed maintenance of the short-term benefits with CBT. However, the studies presented limitations, especially regarding methods, such as lack of a control group and losses to follow-up. Conclusion The long-term benefits of CBT were identified, however it would be interesting to conduct other studies with more frequent assessment periods, in order to minimize losses to follow-up, in addition to evaluating children and adolescents in the various stages of their development.

Are antidepressants effective in quality of life improvement among children and adolescents? A systematic review

CNS Spectrums ◽  
2013 ◽  
Vol 19 (2) ◽  
pp. 134-141 ◽  
Author(s):  
Dejan Stevanovic ◽  
Ivana Tadic ◽  
Rajna Knez
Keyword(s):  
Quality Of Life ◽  
Systematic Review ◽  
Clinical Trials ◽  
Anxiety Disorders ◽  
Children And Adolescents ◽  
Antidepressant Treatment ◽  
Positive Effects ◽  
Related Quality ◽  
Health Related

There is some evidence indicating that psychotropic medications might lead to health-related quality of life (QOL) improvements among children and adolescents with psychiatric disorders. The aim of this systematic review is to assess evidence regarding whether antidepressant treatment improves QOL among children and adolescents with depressive or anxiety disorders. A comprehensive search resulted in 5 clinical trials to be included in this review: 4 trials with major depressive disorder (MDD) and 1 trial with social anxiety disorder (SAD). In one MDD trial, fluoxetine combined with cognitive behavior therapy (CBT) significantly improved QOL compared to fluoxetine or CBT alone (effect sizes were 0.53 and 0.69, respectively). In 2 combined trials, sertraline alone significantly improved QOL among adolescents with MDD (effect size was 0.29), but not among children with MDD. Essentially, it was observed that antidepressants in these trials had minor positive effects on QOL improvement, which were lower than their potential to improve depressive symptoms. Although fluoxetine with CBT or sertraline monotherapy were shown to have some potential to improve QOL, this systematic review found inconclusive evidence that antidepressant treatments improve QOL among children and adolescents with depressive or anxiety disorders. More research is required, considering that QOL is currently under-evaluated in clinical trials with antidepressants among children and adolescents and available trials have limited methodological quality when reporting QOL data.

Sign in / Sign up

Export Citation Format

Share Document